On July 19, HHS and the Departments of Labor and Treasury took an important step to remove insurance copayment requirements as a barrier to access to HIV preexposure prophylaxis (“PrEP”)…
On July 11, the U.S. House Appropriations Committee approved the fiscal year (FY) 2022 appropriations bill (the “Bill”) and accompanying report for the Department of Labor, HHS, Education, and Related…
The following article was originally posted on The Parkersburg News and Sentinel’s website, https://www.newsandsentinel.com, on July 13, 2021. Most patients are likely unaware of the ins and outs of the…
Sending Office: Honorable David B. McKinley Sent By: Kirsten.Wing@mail.house.gov Co-Sponsor Bipartisan Legislation to Improve the Health Care Safety Net and Protect 340B Supported by: 340B Health, America’s Essential Hospitals, National…
On Friday, July 9, Reps. David B. McKinley (R-WV) and Abigail Spanberger (D-VA) introduced the Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B Act (H.R. 4390), which seeks…
On June 23, 2021, drug manufacturer United Therapeutics (UT) filed a lawsuit in the U.S. District Court for the District of Columbia against HHS, alleging that HHS’s policy on contract…
The following press release was posted on Rep. David B. McKinley’s (R-WV-1) website on May 19, 2021. The press release can be accessed by clicking HERE. WASHINGTON – Today, Reps. David…
PRESS STATEMENT: FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com July 9, 2021: RWC-340B, a national association of Ryan White HIV clinics, enthusiastically supports introduction of the PROTECT Act by Representatives McKinley (R-WV)…
The Supreme Court has agreed to review three cases in its next term that have potential impact on 340B covered entities. First, the Supreme Court will review AHA, et al.…
By letter dated June 30, 2021, drug manufacturer Boehringer Ingelheim Pharmaceuticals, Inc. notified covered entities that it will no longer honor all 340B contract pharmacy arrangements, effective August 1, 2021. …